139 related articles for article (PubMed ID: 21450378)
1. Survey of the use of tests for human papilloma virus and epidermal growth factor receptor for squamous cell carcinoma of the head and neck in UK head and neck multidisciplinary teams.
Ahmed A; Cascarini L; Sandison A; Clarke P
Br J Oral Maxillofac Surg; 2012 Mar; 50(2):119-21. PubMed ID: 21450378
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.
Ang KK; Sturgis EM
Semin Radiat Oncol; 2012 Apr; 22(2):128-42. PubMed ID: 22385920
[TBL] [Abstract][Full Text] [Related]
3. Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus-associated head and neck squamous cell carcinoma?
Thomas J; Primeaux T
Ann Diagn Pathol; 2012 Apr; 16(2):91-9. PubMed ID: 22197546
[TBL] [Abstract][Full Text] [Related]
4. Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
Fischer C; Zlobec I; Stöckli E; Probst S; Storck C; Tornillo L; Lugli A; Wolfensberger M; Terracciano L
Hum Pathol; 2008 Oct; 39(10):1527-34. PubMed ID: 18620726
[TBL] [Abstract][Full Text] [Related]
5. Human papilloma virus: a new risk factor in a subset of head and neck cancers.
Bisht M; Bist SS
J Cancer Res Ther; 2011; 7(3):251-5. PubMed ID: 22044803
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma.
Ch'ng S; Low I; Ng D; Brasch H; Sullivan M; Davis P; Tan ST
Hum Pathol; 2008 Mar; 39(3):344-9. PubMed ID: 18045646
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic impact of human papilloma virus in head and neck cancer.
Heffernan CB; O'Neill JP; Timon C
J Laryngol Otol; 2010 Sep; 124(9):941-4. PubMed ID: 20519038
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor.
Fei J; Hong A; Dobbins TA; Jones D; Lee CS; Loo C; Al-Ghamdi M; Harnett GB; Clark J; O'Brien CJ; Rose B
Ann Surg Oncol; 2009 Oct; 16(10):2908-17. PubMed ID: 19603236
[TBL] [Abstract][Full Text] [Related]
9. Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma.
Young RJ; Rischin D; Fisher R; McArthur GA; Fox SB; Peters LJ; Corry J; Lim A; Waldeck K; Solomon B
Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1230-7. PubMed ID: 21467228
[TBL] [Abstract][Full Text] [Related]
10. The relationship between p16 expression and high-risk human papillomavirus infection in squamous cell carcinomas from sites other than uterine cervix: a study of 137 cases.
Doxtader EE; Katzenstein AL
Hum Pathol; 2012 Mar; 43(3):327-32. PubMed ID: 21840041
[TBL] [Abstract][Full Text] [Related]
11. Role of molecular markers and gene profiling in head and neck cancers.
Gold KA; Kim ES
Curr Opin Oncol; 2009 May; 21(3):206-11. PubMed ID: 19346943
[TBL] [Abstract][Full Text] [Related]
12. Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma.
Perrone F; Suardi S; Pastore E; Casieri P; Orsenigo M; Caramuta S; Dagrada G; Losa M; Licitra L; Bossi P; Staurengo S; Oggionni M; Locati L; Cantu G; Squadrelli M; Carbone A; Pierotti MA; Pilotti S
Clin Cancer Res; 2006 Nov; 12(22):6643-51. PubMed ID: 17121883
[TBL] [Abstract][Full Text] [Related]
13. Relationships between epidermal growth factor receptor expression and human papillomavirus status as markers of prognosis in oropharyngeal cancer.
Hong A; Dobbins T; Lee CS; Jones D; Jackson E; Clark J; Armstrong B; Harnett G; Milross C; O'Brien C; Rose B
Eur J Cancer; 2010 Jul; 46(11):2088-96. PubMed ID: 20537890
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus in head and neck cancers: biology, prognosis, hope of treatment, and vaccines.
Psyrri A; Boutati E; Karageorgopoulou S
Anticancer Drugs; 2011 Aug; 22(7):586-90. PubMed ID: 21403517
[TBL] [Abstract][Full Text] [Related]
15. Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer.
Nichols AC; Finkelstein DM; Faquin WC; Westra WH; Mroz EA; Kneuertz P; Begum S; Michaud WA; Busse PM; Clark JR; Rocco JW
Clin Cancer Res; 2010 Apr; 16(7):2138-46. PubMed ID: 20233885
[TBL] [Abstract][Full Text] [Related]
16. [Metastatic oropharyngeal squamous cell carcinoma in cervical lymph nodes associated to HPV infection type 16 and 45; clinical, morphological and molecular study of two cases].
Soria-Céspedes D; Canchola Aguilar G; Lara-Torres CO; Sánchez-Marle JF; Hernández-Peña RE; Ortiz-Hidalgo C
Gac Med Mex; 2013; 149(6):673-9. PubMed ID: 24276191
[TBL] [Abstract][Full Text] [Related]
17. Correlation of biomarkers in head and neck squamous cell carcinoma.
Tse GM; King AD; Yu AM; Lam CC; Chan AW; Chen GG; Yeung DK; Yu KH; Bhatia KS; Chan AB
Otolaryngol Head Neck Surg; 2010 Dec; 143(6):795-800. PubMed ID: 21109080
[TBL] [Abstract][Full Text] [Related]
18. Basaloid squamous cell carcinoma of the head and neck: role of HPV and implication in treatment and prognosis.
Thariat J; Badoual C; Faure C; Butori C; Marcy PY; Righini CA
J Clin Pathol; 2010 Oct; 63(10):857-66. PubMed ID: 20876315
[TBL] [Abstract][Full Text] [Related]
19. Lymphoepithelial-like carcinoma of the oropharynx: a morphologic variant of HPV-related head and neck carcinoma.
Singhi AD; Stelow EB; Mills SE; Westra WH
Am J Surg Pathol; 2010 Jun; 34(6):800-5. PubMed ID: 20421782
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis.
Shin DM; Ro JY; Hong WK; Hittelman WN
Cancer Res; 1994 Jun; 54(12):3153-9. PubMed ID: 8205534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
